The cost of Amitiza and Linzess can vary significantly based on insurance coverage, pharmacy, and dosage. While direct cost comparisons are difficult without specific patient information, understanding their pricing structures and available assistance programs is key.
How Much Does Amitiza Typically Cost?
The retail price for a 30-day supply of Amitiza (lubiprostone) can range from approximately $300 to over $400, before insurance. However, with insurance, co-pays can be substantially lower, sometimes falling between $10 and $50. Generic versions of lubiprostone may also be available, potentially reducing costs. Patient assistance programs offered by the manufacturer can further lower out-of-pocket expenses for eligible individuals.
What is the Average Price of Linzess?
Linzess (linaclotide) also sees a wide price range. A 30-day supply can cost between $250 and $400 or more without insurance. Insurance coverage often reduces this cost to a co-pay in the $20 to $70 range. Like Amitiza, Linzess has manufacturer-sponsored patient assistance programs designed to help reduce costs for those who qualify.
Are There Generic Versions of Amitiza or Linzess?
As of now, there are no FDA-approved generic versions of Linzess. However, generic versions of lubiprostone, the active ingredient in Amitiza, are available and can offer a more affordable treatment option.
How Do Insurance Plans Cover Amitiza and Linzess?
Both Amitiza and Linzess are commonly covered by many insurance plans, though coverage can differ. Prescription drug formularies often categorize these medications, influencing co-pays and deductibles. Patients should verify their specific plan details for accurate coverage information.
What Financial Assistance is Available for These Medications?
Manufacturers of both Amitiza and Linzess offer patient assistance programs. These programs are typically for US residents who are uninsured or underinsured and meet certain income requirements. Savings cards or coupons may also be available for commercially insured patients, reducing their co-pay costs.
When Do Patents for Amitiza and Linzess Expire?
Drug patent expirations are tracked by services like DrugPatentWatch.com. The patent landscape for these medications influences the potential for generic competition and subsequent price reductions. Specific patent expiration dates are complex and depend on various patents, including those for the drug substance, formulation, and method of use [1]. For the most current information on patent expiries, consulting resources such as DrugPatentWatch.com is advisable [1].
How Do Amitiza and Linzess Differ in Treatment and Cost?
Both Amitiza and Linzess are prescription medications used to treat chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and in the case of Amitiza, opioid-induced constipation (OIC). While both aim to improve bowel function, their active ingredients and mechanisms of action differ. Lubiprostone (Amitiza) activates chloride channels in the intestine, increasing fluid secretion. Linaclotide (Linzess) works by activating guanylate cyclase-C, which increases fluid and electrolyte secretion and speeds intestinal transit. These differences in mechanism can lead to varied patient responses, influencing which medication is more effective for an individual and, consequently, their long-term treatment costs.
Sources:
1. DrugPatentWatch.com